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Abstract 
Background: Recent increases in prevalence of peanut allergy has become a significant public 
health concern. There are many risk factors that have been determined to cause development of 
peanut allergies. These risk factors include genetics, race, sex, primary, and secondary 
prevention. Previous guidelines have given no evidence that preventing an infant from allergenic 
foods stunts development of peanut allergy. 
Objectives: The purpose of this integrative literature review was to identify if early exposure to 
peanut prevents occurrence of peanut allergy development.  
Method: An integrative literature review was conducted undergoing extensive search for studies 
that have focused on early exposure to peanut in the infant population from 2006 to 2017. 
Results: Early exposure to high risk infants (infants with severe eczema, egg allergy, or both) 
between the ages of 4 and 11 months old, does prevent peanut allergy development. Follow up 
studies prove that avoiding peanuts for 12 months after, still prevent development of peanut 
allergy.  
Conclusion: This review found evidentiary support for the fact that early exposure to high risk 
infants does prevent development of peanut allergy.  
Keywords: peanut allergy, peanut, allergy, risk factors, management, maternal diet, prevention, 
siblings, and immunology. 
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Introduction 
Background & Significance 
 Peanut allergy is a significant public health concern that can first occur at a young age, is 
rarely outgrown, and can produce severe enough reactions to cause death (Proudfoot & Saul, 
2016).  The prevalence of peanut allergies is growing among younger children. In Western 
countries, 1.4% to 3% of children have a peanut allergy (McCulloch, 2016). Prevalence may 
have tripled in countries like the United States which equates to about 100,000 new cases 
annually in the United States and United Kingdom (Fleischer et al., 2015).  According to John 
Kelso, MD, Allergist in the division of Allergy, Asthma, and Immunology at Scripps Clinic in 
San Diego, children are not born with neither peanut allergies, nor are born with allergies in 
general. John Kelso stated, “children don’t inherit a specific allergy, but rather, a genetic 
tendency to develop allergic disease” (as cited in McCulloch, 2016). A peanut allergy can be 
prevented from occurring if the necessary management is taken early in a child’s life.  
 For the purpose of this literature review, the definition of peanut allergy is that peanuts 
are a part of the legume or soy family. The difference between a peanut and a tree nut is that a 
tree nut is a hard-shelled fruit from a tree (Proudfoot & Saul, 2016). The immunological nature 
of a peanut allergy is induced by peanut protein and the formation of IgE antibodies by a child’s 
immune system (Proudfoot & Saul, 2016). Peanut allergies are most always a type-1 
hypersensitivity response which means that prior sensitization to peanut protein must occur to 
cause the formation of IgE antibodies (Tibbott & Clark, 2014). Prior sensitization can occur in 
utero through breast milk, in eczematous children through a compromised skin barrier, or 
through low-dose environmental exposure e.g. inhalation (Tibbott & Clark, 2014). Once the 
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peanut protein is in the body, the peanut antigen binds to T and B cells which forms the IgE 
antibodies. The IgE antibodies then bind to mast cells and basophils. Upon re-exposure to peanut 
protein, degranulation occurs which releases histamine, tryptase and leukotrienes (Tibbott & 
Clark, 2014). Typical physiologic response includes smooth muscle contraction, mucous 
secretion, vasodilation, and anaphylaxis (Tibbott & Clark, 2014).   
 According to Kim, “In past years, the American Academy of Pediatrics (AAP) and other 
professional groups recommended delaying the introduction of highly allergenic foods, such as 
egg, peanuts, tree nuts, and fish, for 1 to 3 years depending on the food” (2016). A shift in this 
thinking started in 2000 because observational studies have shown that early introduction to 
these foods may actually prevent allergy occurrences. Du Toit stated that, “A cross-sectional 
study of Israeli and UK Jewish children found that the prevalence of peanut allergy (PA) was 10-
fold higher in the UK than in Israel” (2016). This could possibly be due to the fact that Israeli 
infants consume a peanut puff treat called Bamba. A landmark study done in 2006 and published 
in 2015 called Learning Early About Peanut Allergy (LEAP) identified that early exposure to 
peanuts in children more prone to allergy disease showed positive outcomes of the children not 
developing a peanut allergy (Hilton, 2017). Another study called the EAT trial studied food 
allergy prevalence in children with no risk of food allergy (du Toit, 2016).  The outcomes of this 
study are vital in the understanding of the prevention of peanut allergies for children in the 
future.  
Problem statement 
 According to the Centers for Disease Control and Prevention, food allergies increased 
dramatically to about 18% between 1997 and 2007 (Collins 2013). Until recently, the medical 
community set guide lines that recommended pregnant women avoid peanuts and other potential 
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allergens to suggesting that there are no limits on what pregnant women can eat to avoid food 
allergy (Collins, 2013). There is still confusion on whether these studies account for children 
with no history of allergy and whether or not mothers with a peanut allergy will pass this to their 
children. A major study was stared in 2006 called the Learning Early About Peanut Allergy 
(LEAP) trial which tested highly susceptible infants to early exposure to peanuts. This is the 
main study that caused guild lines to be changed about early exposure to allergy prone foods. 
There is a need for more research to be done on the genetic component of allergy disease, if early 
intervention completely reduces the chance of developing a peanut allergy, as well as how 
patient education plays a role in proposing these new guild lines.  
Purpose statement 
 The purpose of this literature review was to (a) explore the most current studies on early 
exposure to peanuts and determine if current guidelines on early exposure will prevent the 
development of peanut allergy in children and (b) to see if there is a genetic component to 
allergy disease and later development of peanut allergy. Infants between the ages of 4-11 months 
will be studied. Children older than the age of ten years will not be examined. This research can 
help when teaching new mothers about their child’s nutrition. In order for new mothers to 
understand the management of risk factors to prevent a peanut allergy occurrence, it is essential 
to understand how food allergies arise. Analyzing previous studies and research will allow for 
cohesive evidence on if mothers should expose their children early to peanuts.  
 Upon analysis of the literature there will be a better understanding of how early exposure 
can prevent development of peanut allergy, as well as if this early exposure will prevent the 
allergy from developing or postpone the development from developing. Accumulating all of the 
literature on early exposure will provide better guidelines on early peanut exposure for infants.  
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Research Questions  
The following research questions are addressed in this literature review: 
1. Does early introduction of peanut protein reduce and prevent the prevalence of peanut 
allergy in children? 
2. How does immunity play a role in allergy disease and later development of peanut 
allergy? 
Conceptual Framework 
 The nurse’s role in managing risk factors to prevent peanut allergies comes in the form of 
patient education. Patient education should center around primary and secondary prevention of 
food allergy. The Health Belief Model (HBM) is a framework that takes into consideration an 
individual’s behavior towards their own health (Becker et al., 1978). In the Health Belief Model, 
whether or not a person undertakes a recommended health action depends on his or her 
perception of the threat of illness, the health action’s potential benefits or efficacy in preventing 
or reducing susceptibility or severity, or both, and physical, psychological, financial, and other 
barriers or costs related to initiating or continuing the advocated behavior (Becker et al., 1978). 
Originally, the HBM focused on preventative actions and avoidance of the threat of disease. 
Now, it has been expanded to help explain compliance to medical regimens after a diagnosis has 
been made (Becker et al., 1978). It has been previous stated that avoidance of possible allergy 
prone foods, like peanuts, be followed for the first 1 to 3 years (Kim, 2016). This belief has now 
been changed since 2015, due to new research studies.  
 The Health Belief Model, along with current research will help educate patients on the 
prevention of possible peanut allergies. The new knowledge gained from the LEAP, EAT, and 
LEAP-ON studies will change the belief that peanuts should be avoided within the first few 
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months of life, and that early exposure has a high chance of limiting the susceptibility of a child 
developing an allergy to peanuts. This will hopefully diminish the occurrence in the future.  
 
 
 
INDIVIDUAL PERCEPTIONS MODIFYING FACTORS LIKELIHOOD OF ACTION 
 
 
 
 
 
 
 
 
 
 
Figure 1: Health Belief Model on Peanut Allergy with Nursing Protocol Implementation 
Figure 1 shows a theoretical model of a patient’s prior belief of early exposure to peanuts.  
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Methods 
Research Design 
 An integrative literature review was used to analyze the studies done on peanut allergy 
prevention in the youth population. This review focused on the interventions and outcomes of 
early exposure to peanut protein in high risk and no risk youth populations. A brief review of 
allergy development in siblings of those with a peanut allergy was conducted, as well as brief 
understanding of IgE antibodies and their role in peanut allergy development. Literature on 
children older than the age of 10 years with a peanut allergy was not be explored, nor was the 
development of adult allergic response to peanuts. Extensive review on other food allergy 
development will not be included. This analysis will provide evidence-based information that 
can be used to help mothers understand the importance of introducing their infants to peanut 
protein within the first months of life. The steps established by Whittmore and Knafl (2005) for 
writing a literature review were used to gather and analyze data in the literature that was found. 
An integrative review of the literature provides the most accurate information about peanut 
allergy prevention studies that have recently changed previous guidelines on what foods to 
expose an infant early in life.  
Literature Search Strategies 
 A computerized search of the literature was performed using DePaul University, as well 
as Rosalind Franklin University of Medicine and Science databases. PubMed and Cumulative 
Index to Nursing and Health Literature (CINAHL) were both used to find relevant literature. 
When using these databases, various text combinations were used for each base. The following 
key words were used in each search: peanut allergy, peanut, allergy, risk factors, management, 
maternal diet, prevention, siblings, and immunology.  
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Literature Search Limitations and Inclusion/Exclusion Criteria 
 Inclusion criteria: The reviewed sources were limited to full text, peer reviewed articles 
from as early as January 2006; articles must be in English; the article must only have research 
done with human subjects; article studies were not limited to the United States.  
 Exclusion criteria: For the purpose of this literature review, only studies done on humans 
were reviewed. Articles that studied children above the age of ten years old were not included.  
 
 
Number of studies found  
using keywords  
 
Number of studies meeting   
Inclusion criteria 
 
Number of studies after 
Using exclusion criteria 
 
Number of studies after 
Excluding duplicates 
 
 
 
 
 
 
 
Table 1: Study Selection & Review of Peanut Allergy Prevalence and Prevention 
 
 
 
CINAHL
n  =101
14
13
11
PubMed
n =38
20
7
5
16 
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Data Synthesis and Analysis 
 All of the data collected from Cumulative Index to Nursing and Health Literature 
(CINAHL) and PubMed were organized into a table based on key words used in the searches. 
Three searches were done to gather all significant data. Table 1 highlights articles found that 
include risk factors, prevention, management, and immunology with regards to peanut allergy. 
Many of the articles found within both databases were duplicates. Articles about peanut allergy 
discussed multiple factors including a brief overview of the immune response in the body, early 
exposure, and outcomes of early exposure.  
 To address the research questions, articles were chosen based on inclusion criteria of risk 
factors and prevention of peanut allergy. Research containing both key words were represented 
multiple times. Searches were done in both databases so the most accurate information and 
studies were found. A total of 101 articles were found using the CINAHL database, and 38 
articles were found from PubMed databases. From this initial number, a total of 34 articles 
specifically met the inclusion criteria. After incorporating the exclusion criteria to this search, a 
total of 20 articles were chosen. Four articles in both database searches were duplicated within 
the search, and were therefore excluded.  
 The second question for this research focused on genetic susceptibility of developing a 
peanut allergy. For this to be answered, peanut allergy and immunology articles were chosen. A 
brief understanding of allergic components in the body will provide better understanding of 
development of peanut allergy in infants that are more susceptible, as well as genetic 
susceptibility of siblings of those infants who are allergic to peanut.  
 The final process of this analysis focused on determining if early exposure studies 
prevented occurrences of peanut allergy in infants who are susceptible to peanut allergy, if a 
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genetic component makes an infant more susceptible to peanut allergy, and if siblings will also 
develop an allergy to peanuts. 
Results 
 To understand how to prevent development of peanut allergy, understanding of causative 
factors needs to be established. Genetic factors are important, but the dramatic increase in peanut 
allergy within a short span of time shows that genetics is not the only factor. Other non- 
modifiable risk factors include race and sex. Modifiable risk factors take into account primary 
and secondary prevention (Du Toit et al., 2016). Primary prevention seeks to prevent the onset of 
IgE sensitization. This targets people without a known peanut allergy (Du Toit et al., 2016). 
Secondary prevention aims to interrupt the development of peanut allergy in IgE sensitized 
children. These are children with allergen-specific IgE or who show a reaction on a skin prick 
test (Du Toit et al., 2016). The Learning Early About Peanut Allergy (LEAP) trial tested to see if 
primary and secondary prevention will decrease the prevalence of peanut allergy in infants.  
Learning Early About Peanut Allergy (LEAP) Trial 
 To examine if early exposure to peanuts prevents development of peanut allergy in 
infants, a study called the LEAP trial was done. Development of the LEAP trial was founded on 
the knowledge that peanut allergy development was 10 times more likely in Jewish children 
living in the United Kingdom, than Israeli children who have a similar background (Du Toit et 
al., 2015). Clinical practice guidelines in the United Kingdom in 1998 and the United States in 
2000 recommended that infants should avoid allergenic foods, such as peanuts, within the first 
months of life, and from the diets of mothers during pregnancy and lactation (Du Toit et al., 
2015).  
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 The LEAP trial focused on infants with a high risk of allergy disease (infants with severe 
eczema and/or egg allergy) (Hilton, 2017). Du Toit et al. explains, “The primary outcome of this 
study was the proportion of participants with peanut allergy at 60 months of age”.  The study was 
a randomized, open-label, controlled trial conducted in the United Kingdom (Du Toit et al., 
2015). Eligible infants for enrollment must be at least 4 months old and less than 11 months of 
age. Infants must also have a history of severe eczema, egg allergy, or both (Du Toit et al., 
2015). These high-risk infants were stratified into one of two groups; no wheal after a skin prick 
test to test for peanut allergy or 1-4mm diameter measure after skin prick test to test for peanut 
allergy. Infants were then randomly assigned to consume or avoid peanut products until 60 
months of age. The consumption group infants were fed at least 6 g of peanut protein per week 
until they reached 60 months of age. Peanut protein was provided in the form of Bamba, which is 
an Israeli peanut butter puffed maize snack for infants. This snack contains approximately 50% 
peanut protein (Hindley et al., 2017). The avoidance group were told to avoid consumption of 
peanut products until infants were 60 months old. Adherence to this regimen was assessed using 
food frequency questionnaires. Clinical assessments were also done at baseline, and at the ages 
of 12, 30, and 60 months of age. Phone consultations were conducted weekly between visits until 
infants reached 12 months of age, every two weeks from ages 12 months to 30 months, and 
every month thereafter (Du Toit et al., 2015).   
 The outcomes of this study revealed positive results. Of the 530 infants with a negative 
skin prick test at baseline, 13.7% of the infants who avoided peanuts until 60 months of age 
tested allergic to peanuts, and only 1.9% of infants who consumed peanuts until 60 months of 
age tested allergic to peanuts (Du Toit et al., 2015). The 98 infants who tested positive with a 
skin prick test at baseline were also examined at 60 months old. Of the 98 infants who avoided 
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peanuts tested positive for a peanut allergy, 35.3% tested positive for peanut allergy and 10.6% 
of infants who consumed peanuts until 60 months of age tested allergic to peanuts. There is now 
scientific evidence that health care providers should now recommend that infants be exposed to 
allergy prone foods early in life (Fleischer et al., 2015). The LEAP trial shows that early peanut 
intervention can greatly reduce the number of infants who will develop a peanut allergy. Some 
limitations were that the LEAP trial only tested high risk infants. Low risk infants or infants with 
wheal diameters larger than 4mm at baseline skin prick testing were not included (Du Toit et al., 
2015). There was also no placebo used, and only oral forms of early introduction were used. 
Peanut dust or inhalants were not included. This monumental study provided enough scientific 
evidence to change guide lines about early exposure to peanut for infants, and shows that peanut 
allergy prevalence can be reduced. 
Persistence of Oral Tolerance to Peanut (LEAP-ON) Study  
 One of the other limitations of the LEAP trial was that infants were only tested at 60 
months of age. The Persistence of Oral Tolerance to Peanut (LEAP-ON) study wanted to 
examine if the participants in the LEAP trial remained protected against peanut allergy after 
cessation of peanut ingestion for 12 months, or if they lost the immunological protection (Du 
Toit et al., 2016). The primary outcome for the LEAP-ON study was the proportion of 
participants who develop a peanut allergy after avoiding peanuts for 12 months (Du Toit et al., 
2016).  
 The participants of the LEAP-ON study were chosen from the participants in the primary 
trial who were assessed for developing a peanut allergy at 60 months old. Participants were 
enrolled from 2011 to 2014. Of these previous participants, 550 would be included in the follow-
up study. 280 participants were instructed to avoid peanuts for 12 months, and 270 participants 
Decreasing peanut allergy occurrence in youth  14 
were instructed to consume peanut products for 12 months. Adherence for the peanut 
consumption group was “consumption of 2 g or less of peanut on no more than 6 occasions 
(maximum of once per month); consumption of 1 g of peanut or less on no more than 12 
occasions (maximum of twice per month); and a cumulative ingestion of no more than 18 g of 
peanut” (Du Toit et al., 2016).  
 Results from the LEAP-ON study showed that at 72 months of age, among the 550 
participants, 18.6% of the participants who avoided peanuts for 12 months had a peanut allergy 
at 72 months old, and 4.8% of the participants who continued to consume peanuts developed a 
peanut allergy at 72 months (Du Toit et al., 2016). While these results did show that participants 
in both parties can develop a peanut allergy, it is far less likely in the group that continued to 
consume peanuts than in the group that avoided peanuts.  
Immunologic Assessments in LEAP Trial and LEAP-ON Study 
 Peanut allergy reactions are caused by IgE mediated, type-1 hypersensitivity response 
(Tibbott & Clark, 2014). Prior sensitization to peanuts causes the formation of IgE antibodies 
(Tibbott & Clark, 2014). Sensitization can occur in utero, through breast milk, in eczematous 
children through a compromised skin barrier, or through low-dose environmental exposure 
(inhalation) (Tibbott & Clark, 2014). IgE antibodies are produced when the body perceives a 
threat. The Ara h 1,2,3, and 6 specific IgE are major components of a peanut allergy, and the 
presence of Ara h 2-specific IgE is responsible for primary peanut allergy with possibly lethal 
results (Tibbott & Clark, 2014).  
 IgE, IgG, and IgG4 markers were tested at baseline on infants who participated in the 
LEAP trial. Skin prick tests were done to measure diameter of the wheal, with the lowest value 
being 1mm and upper limit being 4mm in diameter (Du Toit et al., 2015). Throughout the trial, 
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immune makers and skin prick diameters were measured at 12, 30, and 60 months of age. 
Results showed that wheal size increased only in the peanut avoidance group (Du Toit et al., 
2015). Levels of IgE increased in both groups, however, a significant rise in serum IgE levels 
was measured in the peanut avoidance group when re-exposed to peanuts (Du Toit et al., 2015).  
 In the LEAP-ON study, similar results were found. The mean Ara h2-specific IgE levels 
declined significantly in the group of participants who consumed peanuts (Du Toit et al., 2016). 
This information can guide further researchers to better understand how allergy and specific 
immunoglobulins can affect peanut allergy development in infants.  
Sibling Risk of Developing Peanut Allergy 
  One of the many questions parents ask if one of their children is found allergic to 
peanuts is whether there is an increased risk for their other children to develop a peanut allergy. 
The Study of Asthma, Genes, and the Environment (SAGE) project sought to determine if 
younger siblings of peanut allergic children should be tested for potential development of peanut 
allergy. Approximately 14,000 Canadian children were used in this study done in 1995 (Liem et 
al., 2008). A child health and home environment questionnaire was sent out and had questions 
pertaining to presence of asthma, food allergy and other atopic conditions (Liem et al., 2008). 
Skin testing to peanut and serum lab values of IgE were performed on 603 children. A Sibling 
Food Allergy survey was sent to 560 of the 603 children, and 92% (n=514/560) of families 
completed the survey (Liem et al., 2008). Of these 514 children, 450 were not allergic or 
sensitized to peanut (child can eat peanuts and has a negative skin prick test). 29 children were 
defined as peanut allergic, 8 were sensitized but not allergic, and 27 did not have siblings (Liem 
et al., 2008). The odds ratio of a child who is allergic to peanuts having a sibling who is also 
allergic is 7.12, and the odds ratio of a younger sibling also having a peanut allergy is 11.76.  
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 This study revealed that a sibling of a peanut allergic child has a dramatic increase in 
developing a peanut allergy. Their risk is nearly 7% higher of developing an allergy than those 
who do not have a sibling with a peanut allergy. These results along with other studies done by 
Emmett and colleagues, Hourihane and colleagues, and Sicherer and colleagues will help educate 
parents on how to prevent development of peanut allergy in their children. (Liem et al., 2008). 
Discussion 
 Genetics, race, sex, and primary and secondary prevention are all risk factors that can 
contribute to a developed peanut allergy. Although genetics, race, and sex cannot be changed, 
factors like primary and secondary prevention can dramatically decrease the chance that a child 
develops an allergy to peanuts. Primary prevention can begin with a health care provider 
informing new parents of the updated research about early exposure to peanuts. A provider can 
also suggest early allergy screening for children. With data collected from the LEAP and LEAP-
ON studies, it can be inferred that early exposure to highly allergenic foods, such as peanuts, 
provides better outcomes of not developing an allergy than it would if these foods were avoided 
early in life. With this information, the rise in peanut allergies should decrease over time.  
 It is important to note that there is still research being done on genetic factors and the 
development of peanut allergies. Along with this is the question of whether maternal or paternal 
peanut allergy will cause the child to develop an allergy, as well, since the peanut product will 
most likely be avoided in the household. There is also question of whether sibling development 
of a peanut allergy will cause the other children to be at a higher risk of developing the same 
allergy. 
Limitations 
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 Because this was a literature review, many sources were used to collect data on this 
research topic. The most prominent limitation were the studies population sizes, reliability of the 
families to adhere to the study protocols, limitation of different races and ethnicities that 
participated, and time length of studies. Further research on the families who participated in the 
studies, as well as, other studies on a new population but with the same parameters of the LEAP 
and LEAP-ON study would be helpful in confirming the results. 
Direction for Future Research 
 There are many different tangents from the original LEAP study that could be further 
researched. Other research studies could focus more on the genetic factor for development of 
peanut allergy, as well as if parental or sibling allergy will play a part in how peanut allergies 
develop in families. There is also the question of whether a mother can consume peanut products 
while breastfeeding, and if there is an effect of developing a peanut allergy through that route.  
Nursing Implications 
 Technology, research, and the internet are greatly changing the world of medicine and 
nursing. Many people, turn to the internet or others for medical advice. Thus, the most important 
nursing implication for this study is nursing awareness towards patient education and health 
promotion. A nurse should use patient centered care when working with children and their 
families. Many times, new parents turn to parenting books or others for advice on how to parent 
their child. As a nurse, the most current research should be used when giving advice or educating 
parents on what is best for their child, in regard to early exposure to peanut products. These two 
studies have shown that early exposure can greatly reduce the chance that a child will develop a 
peanut allergy. A nurse should be able to use this information in summation to educate new 
parents. Nurses should also be able to recognize and work with parents who are more skeptical to 
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this new research. It is always best to stay current on new research, especially when engaging in 
patient education. 
Conclusion 
The most important nursing implication for this study is nursing awareness towards 
patient education and health promotion. One of the roles of a nurse is to provide patient 
education in order to maintain and promote health. While there is more extensive research that 
needs to be done with regard to the genetic factors of the development of peanut allergies, 
researchers who published the LEAP and LEAP-ON study have shown that early intervention of 
exposure to peanuts can greatly reduce the development of the allergy. Recognizing that some 
parents might be reluctant to change with this new research is also an important nursing 
implication. Nurses must stay current when teaching patients about new information. There are 
many resources that nurses can provide to parents to ease this tension and develop trust among 
their patients. 
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Table 1: Research Matrix 
Author & Year Sample 
Size 
Study Design & 
Purpose  
Essential 
Components 
Study Outcome 
Du Toit, G., 
Roberts, G., 
Sayre, P. H., 
Bahnson, H. 
T., Radulovic, 
S., Santos, A. 
F., … Lack, G. 
(2015).  
 
N= 640 
infants with 
severe 
eczema, 
egg allergy, 
or both 
Randomized, open-
label, controlled trial 
conducted at a 
single site in the 
United Kingdom. 
Open-label was 
chosen because 
participants and 
their parents were 
aware of the group 
they were assigned 
to.  
640 infants with 
severe eczema, 
egg allergy, or 
both were 
chosen based on 
baseline skin 
prick tests to 
test for allergy 
to peanut 
protein. Infants 
were then either 
instructed to 
consume or 
avoid peanut 
products until 
60 months of 
age.  
Of the 640 
infants, 617 
were able to 
participate in 
the final results 
at 60 months 
old. Infants 
were given 5 g 
of peanut 
protein in one 
sitting. 530 
infants with a 
negative result 
on baseline 
tests were 
evaluated. 
13.7% were 
allergic if 
avoided 
peanuts and 
1.9% were 
allergic if 
consumed 
peanuts. Of the 
98 who tested 
positive at 
baseline, 35.3% 
were allergic if 
avoided 
peanuts, and 
10.6% were 
allergic if 
consumed 
peanuts 
Toit, G. D., Sayre, 
P. H., Roberts, G., 
Sever, M. L., 
Lawson, K., 
Bahnson, H. T., & 
... Du Toit, G. 
(2016) 
 
N=556 of 
the 628 
eligible 
participants 
from the 
primary 
trial (LEAP 
trial) 
A follow-up study This follow-up 
study used 
participants in 
the LEAP trial 
to test whether a 
12 month period 
of avoidance or 
consumption 
Allergy was 
determined by 
oral peanut 
ingestion at 72 
months of age. 
At 72 months, 
18.6% of the 
peanut 
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would cause 
development of 
peanut allergy. 
Primary 
outcome was 
the percentage 
of participants 
with peanut 
allergy after 12 
months of 
peanut 
avoidance.  
avoidance 
group (52 of 
280 
participants) 
and 4.8% of the 
peanut 
consumption 
group (13 of 
270) had a 
peanut allergy.  
Hindley, J. P., 
Filep, S., Block, D. 
S., King, E. M., & 
Chapman, M. D. 
(2017) 
N=16 
(100mg) 
samples of 
different 
lots of 
Bamba 
from either 
the United 
Kingdom 
(n=8) or the 
United 
States 
(n=8) 
N= 25 from 
a single lot 
Bamba products 
were tested using 
ELISA for Ara h1, 
Ara h2, and Ara h6.  
The preferred 
peanut snack 
used in the 
LEAP trial was 
Bamba, so the 
allergen 
composition of 
Bamba, and 
what levels of 
specific peanut 
allergens are 
associated with 
tolerance to 
peanut were 
studied 
Bamba is a 
well-formulated 
peanut product, 
with each of the 
3 major 
allergens 
present in 
uniform 
amounts. The 
estimates 
obtained from 
this study 
suggest that 
cumulative 
weekly doses of 
approximately 
330 mg specific 
peanut 
allergens are 
associated with 
prevention of 
peanut allergy 
 
 
Author & Year Study Design Study Purpose Essential 
Components 
Outcomes 
Coleman 
Collins, S. 
(2013) 
Descriptive 
study. 
Summarized 
maternal diet, 
infant and early 
exposure 
feeding, and 
practice pearls.  
This article 
focused on 
recommendations 
for maternal diet, 
and what 
guidelines said to 
avoid eating 
while pregnant.  
Content includes 
a focus on 
maternal diet, 
breast feeding 
and early child 
and infant 
feeding. 
Discusses how 
States 
researchers have 
not been able to 
determine the 
exact etiology of 
food allergies, 
which is one of 
the reasons food 
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allergenic 
protein may be 
secreted in 
breast milk 
which is an 
infant’s first 
exposure to 
allergenic 
proteins. 
allergy has 
increased. 
Highlights the 
need for further 
research on 
maternal diet 
influences and 
early exposure 
to allergenic 
foods. Also 
states that while 
guidelines on 
early exposure 
to allergenic 
foods has been 
published, 
physicians are 
still going by 
previous 
standards.  
Du Toit, G., 
Tsakok, T., 
Lack, S., & 
Lack, G. (2017). 
Comparative 
descriptive 
design 
Discusses how to 
prevent food 
allergy. Mentions 
risk factors, such 
as genetics, 
family history of 
food allergy, 
male sex, 
ethnicity, and 
atopic dermatitis.  
Discusses 
several 
components of 
food allergy 
development. 
Nonmodifiable 
risks include 
genetics, race, 
and sex, while 
modifiable risks 
include primary 
and secondary 
prevention. 
Primary 
prevention is 
preventing the 
onset of IgE 
sensitization, 
and secondary 
prevention is 
interrupting the 
development of 
food allergy in 
IgE sensitized 
children.  
This article 
summarizes risk 
factors of food 
allergy, and the 
LEAP trial. It 
also goes into 
detail about 
specifics of the 
LEAP trial, such 
as the infant 
population and 
being high risk 
infants, the 
excluded 
children in the 
LEAP trial, if 
the LEAP trial 
will sustain 
peanut allergy 
development, if 
other children 
around the world 
will have same 
results, and if 
this type of 
prevention will 
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result in other 
food allergens 
Fleischer, D. M., 
Sicherer, S., 
Greenhawt, M., 
Campbell, D., 
Chan, E., 
Muraro, A., … 
Rosenwasser, L. 
(2017) 
This article 
summarizes the 
evidence of the 
LEAP trial.  
Provides further 
support of the 
LEAP trial and 
the conclusions 
made. 
Purpose of this 
article was to 
highlight 
emerging 
evidence for 
existing allergy 
prevention 
guidelines. It 
summarizes the 
evidence, and 
gives 
explanation of 
why health care 
providers should 
recommend 
theses new 
guidelines 
Outcomes of this 
article are to 
inform the 
reader that the 
LEAP trial has 
changed 
previous 
guidelines. 
Hilton, L. 
(2017). 
Summary of 
LEAP trial, with 
dermatologist 
insights 
Uses other health 
care provider 
insight to the 
LEAP trial 
results 
Clearly 
summarizes the 
LEAP trial. 
Provides 
dermatologist 
insights. 
States that there 
might be 
discrepancies in 
the definition of 
severe eczema 
between 
pediatricians and 
dermatologists. 
Gives Dr. Peter 
Lio, assistant 
professor of 
clinical 
dermatology and 
pediatrics, 
Northwestern 
University 
Feinberg School 
of Medicine, 
insight as to be 
cautious about 
this new study 
Jae H., K. 
(2016). 
This article 
summarizes 
different 
nutritional 
insights and 
The purpose of 
this article is go 
give information 
on preventing 
allergy and looks 
into why 
Mentions how 
infants with 
atopic dermatitis 
are more 
susceptible to 
develop food 
Support for the 
LEAP trial 
Decreasing peanut allergy occurrence in youth  26 
pediatric 
nutrition.  
previous 
guidelines were 
changed about 
early exposure to 
highly allergenic 
foods.  
allergies. 
Discusses the 
LEAP trial 
McCulloch, M. 
(2016). 
Summary of 
LEAP trial, 
LEAP-ON 
study, and new 
guidelines 
Purpose is to 
educate readers 
on why new 
guidelines have 
arisen.  
Gives tips on 
how to expose 
infants early to 
peanuts. 
Discusses need 
for further 
research on trial 
with infants who 
are not of the 
high risk 
population 
Proposes ideas 
for further 
research 
Proudfoot, C., & 
Saul, P. 
Informational 
summary on 
allergy 
development, 
peanut and tree 
nut allergies, 
and management 
of these allergies 
Purpose is to 
educate readers 
on peanut allergy 
and management 
Discusses 
prevalence, 
allergy 
mechanisms, 
presentation of 
allergy, 
importance of 
history taking 
and physical, 
and management 
strategies to 
prevent reaction 
Patient 
education 
Tibbott, R., & 
Clark, A. 
(2014). 
Descriptive 
summary 
Purpose is to 
condense 
information on 
allergy 
development in 
the body, 
presentation and 
diagnosis of 
peanut allergy, 
and what 
determines the 
severity of a 
reaction 
Breaks down 
how allergy is 
developed in the 
body. Gives 
good 
information on 
the fact that the 
amount of 
peanut protein 
consumed can 
determine 
severity of the 
reaction 
Patient 
education on 
peanut allergy 
and 
management. 
Focus on need 
for other factors 
such as sleep 
and illness and 
how these can 
affect severity of 
a reaction.  
Table 2: Literature sources for risk factors, prevention, management, and immunology with 
regards to peanut allergy. 
